Luke Evnin, Director at Werewolf Therapeutics, Inc. (HOWL), sold 91,374 shares at $0.63 ($54K) on 2026-01-08, disclosed to the SEC on 2026-01-12.
Open-market sale of $54k HOWL by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.63 | 7,716 | $5K | 9.1% |
| 2 | $0.61 | 24,678 | $15K | 28.1% |
| 3 | $0.57 | 58,980 | $34K | 62.8% |
| Total | $0.59 avg | 91,374 | $54K | 100% |
| Filing → |
| HOWL | SELL | 2026-06-10 | $28K | — | Filing → |
| HOWL | SELL | 2026-06-08 | $43K | — | Filing → |
| HOWL | SELL | 2026-06-03 | $64K | — | Filing → |